IMV Inc. (IMVIQ)

0.0000 0.0000 (0.00%) As of 03:53PM EDT. Market open.

IMV Inc.

130 Eileen Stubbs Avenue
Suite 19
Dartmouth, NS B3B 2C4
Canada
902 492 1819
https://www.imv-inc.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 63

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Andrew Hall M.Sc.	CEO & Director	680.6k	N/A	N/A
Ms. Brittany Davison C.A., CPA	Chief Accounting Officer, Corporate Secretary & Director	207.9k	N/A	1990
Delphine Davan	Senior Director of Communications & Investor Relations	N/A	N/A	N/A
Mr. Stephan Fiset M.B.A., M.Sc.	Vice President of Clinical Research	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Corporate governance

IMV Inc.’s ISS governance QualityScore as of 1 May 2024 is 4. The pillar scores are Audit: 6; Board: 7; Shareholder rights: 4; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.